Su et al. carried out a similar study to assess AMH levels in breast cancer patients and found that they were lower than in the non-cancer patients (0.6 ng/mL vs. 1.1 ng/mL, p-value < 0.001) [18]. This evidence concerns the gene AMH and breast carcinoma.